Rosemary Health’s Series Seed-2 Capital Raise

Herbert Smith Freehills advised Rosemary Health on its Series Seed-2 capital raise.

Rosemary Health is a telehealth platform that facilitates electronic prescriptions and prescription deliveries to Australian consumers. This new capital will be employed to accelerate the growth and market penetration of its range of asynchronous telehealth clinics.

The round was led by existing investor and early stage VC fund Artesian Venture Partners, with investors in the round including Singaporean VC fund Vulpes Investment Management, Australian VC fund Spring Capital and US VC fund Breyer Capital.

The Herbert Smith Freehills team was led by partner and Head of Venture Capital Peter Dunne (Picture) and solicitor Myra Beal.  

Involved fees earner: Myra Beal – Herbert Smith Freehills; Peter Dunne – Herbert Smith Freehills;

Law Firms: Herbert Smith Freehills;

Clients: Rosemary Health;

Print Friendly, PDF & Email
Sonia Carcano

Author: Sonia Carcano